Letters to the EditorEculizumab in Acute Motor Axonal Neuropathy: An Ethical Application of an Off-Label IndicationRoy, Bhaskar MD, MMST; Nowak, Richard J. MD, MSAuthor Information Department of Neurology, Yale School of Medicine, New Haven, CT R. J. Nowak has received research support from the National Institutes of Health (NIH), Genentech, Alexion Pharmaceuticals, Ra Pharmaceuticals, Myasthenia Gravis Foundation of America, Momenta, and Grifols. He has served as consultant/advisor for Alexion Pharmaceuticals, CSL Behring, Grifols, Ra Pharmaceuticals, Roivant, and Momenta. B. Roy has served as consultant/advisor for Alexion Pharmaceuticals. The authors report no conflicts of interest. Journal of Clinical Neuromuscular Disease: September 2020 - Volume 22 - Issue 1 - p 63-64 doi: 10.1097/CND.0000000000000295 Buy Metrics Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.